Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Verani

Showing results (231-240 of 259) with videos related to

Pageof 26
Sort By:
Lancet (London, England)|March 18, 2020
First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USAIsaac Ghinai, Tristan D McPherson, Jennifer C Hunter, et al.
Public Health Reports (Washington, D.C. : 1974)|October 28, 2020
Lack of Serologic Evidence of Infection Among Health Care Personnel and Other Contacts of First 2 Confirmed Patients With COVID-19 in Illinois, 2020Tristan D McPherson, Isaac Ghinai, Alison M Binder, et al.
MMWR. Morbidity and Mortality Weekly Report|August 12, 2021
Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years - COVID-NET, 13 States, February-April 2021Heidi L Moline, Michael Whitaker, Li Deng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 2, 2021
Deaths Attributed to Respiratory Syncytial Virus in Young Children in High-Mortality Rate Settings: Report from Child Health and Mortality Prevention Surveillance (CHAMPS)Dianna M Blau, Vicky L Baillie, Toyah Els, et al.
The Lancet. Child & Adolescent Health|January 28, 2024
Post-mortem investigation of deaths due to pneumonia in children aged 1-59 months in sub-Saharan Africa and South Asia from 2016 to 2022: an observational studySana Mahtab, Dianna M Blau, Zachary J Madewell, et al.
The New England Journal of Medicine|September 8, 2021
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care SettingsMark G Thompson, Edward Stenehjem, Shaun Grannis, et al.
MMWR. Morbidity and Mortality Weekly Report|January 27, 2022
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022Mark G Thompson, Karthik Natarajan, Stephanie A Irving, et al.
Pediatrics|April 7, 2023
Effectiveness of BNT162b2 COVID-19 Vaccination in Children and AdolescentsNicola P Klein, Maria Demarco, Katherine E Fleming-Dutra, et al.
The New England Journal of Medicine|September 22, 2021
Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care PersonnelTamara Pilishvili, Ryan Gierke, Katherine E Fleming-Dutra, et al.
MMWR. Morbidity and Mortality Weekly Report|March 3, 2022
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022Nicola P Klein, Melissa S Stockwell, Maria Demarco, et al.
Pageof 26

Showing results (231-240 of 259) with videos related to

Sort By:
Pageof 26
Lancet (London, England)|March 18, 2020
First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USAIsaac Ghinai, Tristan D McPherson, Jennifer C Hunter, et al.
Public Health Reports (Washington, D.C. : 1974)|October 28, 2020
Lack of Serologic Evidence of Infection Among Health Care Personnel and Other Contacts of First 2 Confirmed Patients With COVID-19 in Illinois, 2020Tristan D McPherson, Isaac Ghinai, Alison M Binder, et al.
MMWR. Morbidity and Mortality Weekly Report|August 12, 2021
Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years - COVID-NET, 13 States, February-April 2021Heidi L Moline, Michael Whitaker, Li Deng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 2, 2021
Deaths Attributed to Respiratory Syncytial Virus in Young Children in High-Mortality Rate Settings: Report from Child Health and Mortality Prevention Surveillance (CHAMPS)Dianna M Blau, Vicky L Baillie, Toyah Els, et al.
The Lancet. Child & Adolescent Health|January 28, 2024
Post-mortem investigation of deaths due to pneumonia in children aged 1-59 months in sub-Saharan Africa and South Asia from 2016 to 2022: an observational studySana Mahtab, Dianna M Blau, Zachary J Madewell, et al.
The New England Journal of Medicine|September 8, 2021
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care SettingsMark G Thompson, Edward Stenehjem, Shaun Grannis, et al.
MMWR. Morbidity and Mortality Weekly Report|January 27, 2022
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022Mark G Thompson, Karthik Natarajan, Stephanie A Irving, et al.
Pediatrics|April 7, 2023
Effectiveness of BNT162b2 COVID-19 Vaccination in Children and AdolescentsNicola P Klein, Maria Demarco, Katherine E Fleming-Dutra, et al.
The New England Journal of Medicine|September 22, 2021
Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care PersonnelTamara Pilishvili, Ryan Gierke, Katherine E Fleming-Dutra, et al.
MMWR. Morbidity and Mortality Weekly Report|March 3, 2022
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022Nicola P Klein, Melissa S Stockwell, Maria Demarco, et al.
Pageof 26